| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2007;115:1858-1865.)
© 2007 American Heart Association, Inc.
Coronary Heart Disease |
From the Departments of Nutrition (Q.S., H.C., M.J.S., W.C.W., F.B.H.) and Epidemiology (Q.S., S.E.H., J.E.M., M.J.S., W.C.W., F.B.H), Harvard School of Public Health; Channing Laboratory (J.M., S.E.H., J.E.M., M.J.S., W.C.W., F.B.H.) and Division of Preventive Medicine (J.E.M., M.J.S., K.M.R., W.C.W.), Department of Medicine, Brigham and Womens Hospital and Harvard Medical School, Boston, Mass.
Correspondence to Frank B. Hu, MD, PhD, Department of Nutrition, Harvard School of Public Health, 665 Huntington Ave, Boston, MA 02115. E-mail frank.hu{at}channing.harvard.edu
Received November 29, 2006; accepted January 24, 2007.
Background High consumption of trans fat has been linked to the risk of coronary heart disease (CHD). We assessed the hypothesis that higher trans fatty acid contents in erythrocytes were associated with an elevated risk of CHD in a nested case-control study among US women.
Methods and Results Blood samples were collected from 32 826 participants of the Nurses Health Study from 1989 to 1990. During 6 years of follow-up, 166 incident cases of CHD were ascertained and matched with 327 controls. Total trans fatty acid content in erythrocytes was significantly correlated with dietary intake of trans fat (correlation coefficient=0.44, P<0.01) and was associated with increased plasma low-density lipoprotein cholesterol (P for trend =0.06), decreased plasma high-density lipoprotein cholesterol concentrations (P for trend <0.01), and increased plasma low-density lipoprotein to high-density lipoprotein ratio (P for trend <0.01). After adjustment for age, smoking status, and other dietary and lifestyle cardiovascular risk factors, higher total trans fatty acid content in erythrocytes was associated with an elevated risk of CHD. The multivariable relative risks (95% confidence intervals) of CHD from the lowest to highest quartiles of total trans fatty acid content in erythrocytes were 1.0 (reference), 1.6 (0.7 to 3.6), 1.6 (0.7 to 3.4), and 3.3 (1.5 to 7.2) (P for trend <0.01). The corresponding relative risks were 1.0, 1.1, 1.3, and 3.1 (P for trend <0.01) for a total of 18:1 trans isomers and 1.0, 1.5, 2.5, and 2.8 (P for trend <0.01) for a total of 18:2 trans isomers.
Conclusions These biomarker data provide further evidence that high trans fat consumption remains a significant risk factor for CHD after adjustment for covariates.
Find additional patient-related information at:
Related Article:
This article has been cited by other articles:
![]() |
Q. Sun, M. K Townsend, O. I Okereke, O. H Franco, F. B Hu, and F. Grodstein Adiposity and weight change in mid-life in relation to healthy survival after age 70 in women: prospective cohort study BMJ, September 29, 2009; 339(sep29_1): b3796 - b3796. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Bassuk and J. E. Manson Lifestyle and Risk of Cardiovascular Disease and Type 2 Diabetes in Women: A Review of the Epidemiologic Evidence American Journal of Lifestyle Medicine, June 1, 2008; 2(3): 191 - 213. [Abstract] [PDF] |
||||
![]() |
V. Chajes, A. C. M. Thiebaut, M. Rotival, E. Gauthier, V. Maillard, M.-C. Boutron-Ruault, V. Joulin, G. M. Lenoir, and F. Clavel-Chapelon Association between Serum trans-Monounsaturated Fatty Acids and Breast Cancer Risk in the E3N-EPIC Study Am. J. Epidemiol., June 1, 2008; 167(11): 1312 - 1320. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Motard-Belanger, A. Charest, G. Grenier, P. Paquin, Y. Chouinard, S. Lemieux, P. Couture, and B. Lamarche Study of the effect of trans fatty acids from ruminants on blood lipids and other risk factors for cardiovascular disease Am. J. Clinical Nutrition, March 1, 2008; 87(3): 593 - 599. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. K. Kabagambe, M. Y. Tsai, P. N. Hopkins, J. M. Ordovas, J. M. Peacock, I. B. Borecki, and D. K. Arnett Erythrocyte Fatty Acid Composition and the Metabolic Syndrome: A National Heart, Lung, and Blood Institute GOLDN Study Clin. Chem., January 1, 2008; 54(1): 154 - 162. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Spector and W. G. Haynes LDL Cholesteryl Oleate: A Biomarker for Atherosclerosis? Arterioscler Thromb Vasc Biol, June 1, 2007; 27(6): 1228 - 1230. [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |